Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Shindo (Kyoto, Japan), N. Tanabe (Kyoto, Japan), A. Sato (Kyoto, Japan), K. Uemasu (Kyoto, Japan), H. Shima (Kyoto, Japan), T. Mizutani (Kyoto, Japan), E. Ogawa (Shiga, Japan), S. Muro (Nara, Japan), S. Sato (Kyoto, Japan), T. Hirai (Kyoto, Japan). Pathology of small airways in non-COPD smokers with low diffusion capacity and patients with COPD. 1247

Member's Comments

No comment yet.

Related content which might interest you: Expression of versican in large and small airways and parenchyma in lungs of non-smokers, smokers and COPD patients Source: Annual Congress 2009 - Highlighting the epithelial cell in lung disease: from COPD to cancer to acute lung injury Year: 2009 Enhanced T cell growth from bronchial biopsies of COPD ex-smokers and severe asthmatic subjects compared to COPD current smokers Source: Eur Respir J 2004; 24: Suppl. 48, 39s Year: 2004 Airway and systemic inflammation profile in current smokers controls, COPD current smokers and COPD ex-smokers Source: Annual Congress 2009 - Biomarkers and biology in COPD Year: 2009 Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity Source: Eur Respir J 2015; 46: 1589-1597 Year: 2015 The lower airways microbiome in patients with IPF and COPD Source: International Congress 2019 – Innovations in idiopathic pulmonary fibrosis Year: 2019 Pathology of small airways in COPD Source: Research Seminar 2010 - The role of small airways in obstructive pulmonary diseases Year: 2010 Airway pathology in COPD compared to that in smokers with asthma Source: Annual Congress 2008 - Smokers with asthma versus COPD: differences and similarities Year: 2008 Bronchial biopsies composition in smokers and nonsmokers in COPD exacerbation Source: Eur Respir J 2004; 24: Suppl. 48, 411s Year: 2004 Comparison of breath VOCs collected from controls, healthy smokers, smokers with COPD, and ex-smokers with COPD at two sites Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Small airways disease evaluation in healthy smokers with normal spirometry values Source: International Congress 2019 – Physiologic assessment of airway diseases Year: 2019 Clinical consideration and lung function in different groups of COPD patients (smokers, ex-smokers, nonsmokers) Source: International Congress 2017 – Smoking and health hazards Year: 2017 Airways and systemic inflammation and correlation to lung function in smokers and in COPD patients Source: Eur Respir J 2006; 28: Suppl. 50, 651s Year: 2006 ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19 Source: Eur Respir J, 55 (5) 2000688; 10.1183/13993003.00688-2020 Year: 2020 Budesonide/formoterol significantly improves lung function and reduces exacerbations in both smokers and ex-smokers with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 430s Year: 2006 Pathology of small airways dysfunction in COPD Source: International Congress 2017 – From small airways dysfunction to dyspnoea in COPD: from physiology to clinical application Year: 2017 Airway resistance and reactance in COPD patients and healthy smokers, and effect of bronchodilators Source: Annual Congress 2011 - Treatment strategies, systemic manifestations and biomarkers in airway diseases Year: 2011 Bronchial biopsies cells count in smokers and nonsmokers in COPD exacerbation Source: Eur Respir J 2006; 28: Suppl. 50, 575s Year: 2006 Increased circulating alveolar epithelial microparticles in COPD patients Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Decreased pulmonary mature dendritic cells in healthy smokers and smoking COPD patients Source: Eur Respir J 2007; 30: Suppl. 51, 212s Year: 2007 Indications of small airways disease in healthy smokers Source: Annual Congress 2012 - COPD: epidemiology and varia Year: 2012